What's in Senju Pharmaceutical Co., Ltd.'s pipeline?

Senju Pharmaceutical Co., Ltd. has 5 drugs in our index: 2 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Senju Pharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: ADvantage Therapeutics, AJU Pharm Co., Ltd., AO GENERIUM, Abbott, AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/senju-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Senju Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Senju Pharmaceutical Co., Ltd. pipeline: 2 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 2 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Alphagan	BRIMONIDINE	marketed	alpha-Adrenergic Agonist	Alpha-2C adrenergic receptor	Cardiovascular	1996-01-01
Alphagan	BRIMONIDINE TARTRATE	marketed	alpha-Adrenergic Agonist	Alpha-2C adrenergic receptor	Cardiovascular	1996-01-01
SJP-0132	SJP-0132	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
SJP-0035 0.001%	SJP-0035 0.001%	phase 3	Topical ophthalmic solution		Ophthalmology

Therapeutic area mix

Cardiovascular · 2
Diabetes · 1
Ophthalmology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ADvantage Therapeutics · 1 shared drug class
AJU Pharm Co., Ltd. · 1 shared drug class
AO GENERIUM · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class
3D Medicines (Beijing) Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Senju Pharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). Senju Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/senju-pharmaceutical-co-ltd. Accessed 2026-05-16.